• 한국식품과학회지
• /
• 제38권6호
• /
• pp.767-772
• /
• 2006

유산균의 일종인 Lactobacillus sp.을 중심물질로 하고 그 바깥을 2중층으로 미세캡슐화하는 공정을 위한 최적 조건을 확립하였는데, [중심물질]과 [피복물질]의 혼합비율과 유화제 첨가농도, 2중층 유화계내의 2종류 유화제(PGPR/PSML)에 의한 상승효과, 분산액의 온도 및 분산액의 교반속도가 유산균함유 2중층 미세캡슐화 수율에 미치는 영향을 검토하였다. W/O형 및 W/O/W형 유화계내에서의 중심물질과 피복물질의 혼합비율과 유화제 첨가농도에 다른 최적조건을 탐색한 결과, Lactobacillus sp.(Cm)와 옥배경화유(Wm)와의 혼합비율이 [W/O형 Cm]:[W/O형 Wm]=3:2(w/w), 1.00%의 유화제(PGPR) 첨가농도에서 최대의 수율을 나타내었으며, 유산균을 옥배경화유가 단일층으로 둘러싼 W/O형 유화계와 다당류 호화액의 혼합비율 즉, [W/O/W형 중심물질, CM]:[W/O/W형 피복물질, WM]=1:3(w/w) 0.65%의 유화제(PSML) 농도에서 가장 높은 미세캡슐화 수율을 얻을 수 있은 것으로 판명되었다. 최종적으로, 유산균 2중층 미세캡슐화 공정을 위한 여러 가지 요인들 중 물리적인 조건의 변화를 살펴본 결과, 분산매의 온도가 10$^{\circ}C$이며, 미세캡슐을 함유하는 분산액 제조시의 교반정도가 270rpm일 때 2중 미세캡슐화의 가장 높은 수율을 확인 할 수 있다.

• Preventive Nutrition and Food Science
• /
• 제12권1호
• /
• pp.58-63
• /
• 2007

Bifidobacteria are probiotic organisms that provide both flavor and health benefits when incorporated as live cultures into commercial dairy products. Because bifidobacteria are very sensitive to environmental conditions (acids, temperature, oxygen, bile salts, the presence of other cultures, etc.), their viability in human gastrointestinal tract is limited. The microencapsulation of bifidobacteria is a process to protect them against harsh environmental conditions, thereby increasing their viability while passing through human gastrointestinal tract. To confirm the survival rate of microencapsulated Bifidobacterium breve CBG-C2 in milk, their survival rate was compared with several kinds of free bifidobacteria and lactic acid bacteria in commercial yogurt products under simulated gastric and small intestinal conditions. Double-microencapsulation of the bacteria was employed to increase the survival rate during digestion. The outer layer was covered with starch and gelatin to endure gastric conditions, and the inner layer was composed of a hard oil for the upper small intestinal regions. Almost all microencapsulted bifidobacteria in the milk survived longer than the free bifidobacteria and lactic acid bacteria in the commericial yogurt products under the simulated gastric conditions. Numbers of surviving free bifidobacteria and lactic acid bacteria in the commercial products were significantly reduced, however, the viability of the microencapsulated bificobacteria in the milk remained quite stable under gastric and small intestine conditions over 3$\sim$6 hrs. Thus double-microencapsualtion of bifidobacteria in milk is a promising method for improving the survival of bifidobacteria during the digestive process.